Collaborative investigation of the accuracy and reproducibility of Sceptor Breakpoint susceptibility panels

Gerald Denys, S. L. Hansen, W. A. Pope, H. Lilli, J. M. Hejna

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A combination Sceptor Breakpoint/ID panel (Johnston Laboratories, Inc., Towson, Md.), which determines interpretive susceptibility results (susceptible, moderately susceptible, and resistant) using two to three selected concentrations of antimicrobial agents, was tested in comparison with full-range Sceptor microdilution MIC panels. The inter- and intralaboratory interpretive reproducibilities for 24 control strains tested in three laboratories on three consecutive days were 97.0 and 95.7%, respectively. The equivalency of breakpoint results to category results obtained by the microdilution MIC procedure for 10,368 control organism-antimicrobial agent comparisons was 94.1%. The level of interpretive agreement between breakpoint and MIC category results using 101 fresh clinical isolates was 97.0% for 51 gram-negative and 50 gram-positive bacteria. Among the total 4,872 clinical organism-antimicrobial agent comparisons, major and very major discrepancies were seen in 0.2% of gram-negative bacteria and very major discrepancies were seen in 0.9% of gram-positive bacteria. All very major discrepancies with gram-positive organisms were associated with trailing endpoints using trimethoprim or sulfisoxazole and staphylococci. The breakpoint concept of testing selective antimicrobial agent concentrations was highly reproducible and accurate and allows for placement of more antimicrobial agents into a panel than is possible with full-dilution MIC testing.

Original languageEnglish (US)
Pages (from-to)2189-2192
Number of pages4
JournalJournal of clinical microbiology
Volume25
Issue number11
StatePublished - Jan 1 1987
Externally publishedYes

Fingerprint

Anti-Infective Agents
Gram-Positive Bacteria
Sulfisoxazole
Trimethoprim
Gram-Negative Bacteria
Staphylococcus

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Collaborative investigation of the accuracy and reproducibility of Sceptor Breakpoint susceptibility panels. / Denys, Gerald; Hansen, S. L.; Pope, W. A.; Lilli, H.; Hejna, J. M.

In: Journal of clinical microbiology, Vol. 25, No. 11, 01.01.1987, p. 2189-2192.

Research output: Contribution to journalArticle

Denys, Gerald ; Hansen, S. L. ; Pope, W. A. ; Lilli, H. ; Hejna, J. M. / Collaborative investigation of the accuracy and reproducibility of Sceptor Breakpoint susceptibility panels. In: Journal of clinical microbiology. 1987 ; Vol. 25, No. 11. pp. 2189-2192.
@article{00174a6c2a344ddc95bb0287ea419e61,
title = "Collaborative investigation of the accuracy and reproducibility of Sceptor Breakpoint susceptibility panels",
abstract = "A combination Sceptor Breakpoint/ID panel (Johnston Laboratories, Inc., Towson, Md.), which determines interpretive susceptibility results (susceptible, moderately susceptible, and resistant) using two to three selected concentrations of antimicrobial agents, was tested in comparison with full-range Sceptor microdilution MIC panels. The inter- and intralaboratory interpretive reproducibilities for 24 control strains tested in three laboratories on three consecutive days were 97.0 and 95.7{\%}, respectively. The equivalency of breakpoint results to category results obtained by the microdilution MIC procedure for 10,368 control organism-antimicrobial agent comparisons was 94.1{\%}. The level of interpretive agreement between breakpoint and MIC category results using 101 fresh clinical isolates was 97.0{\%} for 51 gram-negative and 50 gram-positive bacteria. Among the total 4,872 clinical organism-antimicrobial agent comparisons, major and very major discrepancies were seen in 0.2{\%} of gram-negative bacteria and very major discrepancies were seen in 0.9{\%} of gram-positive bacteria. All very major discrepancies with gram-positive organisms were associated with trailing endpoints using trimethoprim or sulfisoxazole and staphylococci. The breakpoint concept of testing selective antimicrobial agent concentrations was highly reproducible and accurate and allows for placement of more antimicrobial agents into a panel than is possible with full-dilution MIC testing.",
author = "Gerald Denys and Hansen, {S. L.} and Pope, {W. A.} and H. Lilli and Hejna, {J. M.}",
year = "1987",
month = "1",
day = "1",
language = "English (US)",
volume = "25",
pages = "2189--2192",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Collaborative investigation of the accuracy and reproducibility of Sceptor Breakpoint susceptibility panels

AU - Denys, Gerald

AU - Hansen, S. L.

AU - Pope, W. A.

AU - Lilli, H.

AU - Hejna, J. M.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - A combination Sceptor Breakpoint/ID panel (Johnston Laboratories, Inc., Towson, Md.), which determines interpretive susceptibility results (susceptible, moderately susceptible, and resistant) using two to three selected concentrations of antimicrobial agents, was tested in comparison with full-range Sceptor microdilution MIC panels. The inter- and intralaboratory interpretive reproducibilities for 24 control strains tested in three laboratories on three consecutive days were 97.0 and 95.7%, respectively. The equivalency of breakpoint results to category results obtained by the microdilution MIC procedure for 10,368 control organism-antimicrobial agent comparisons was 94.1%. The level of interpretive agreement between breakpoint and MIC category results using 101 fresh clinical isolates was 97.0% for 51 gram-negative and 50 gram-positive bacteria. Among the total 4,872 clinical organism-antimicrobial agent comparisons, major and very major discrepancies were seen in 0.2% of gram-negative bacteria and very major discrepancies were seen in 0.9% of gram-positive bacteria. All very major discrepancies with gram-positive organisms were associated with trailing endpoints using trimethoprim or sulfisoxazole and staphylococci. The breakpoint concept of testing selective antimicrobial agent concentrations was highly reproducible and accurate and allows for placement of more antimicrobial agents into a panel than is possible with full-dilution MIC testing.

AB - A combination Sceptor Breakpoint/ID panel (Johnston Laboratories, Inc., Towson, Md.), which determines interpretive susceptibility results (susceptible, moderately susceptible, and resistant) using two to three selected concentrations of antimicrobial agents, was tested in comparison with full-range Sceptor microdilution MIC panels. The inter- and intralaboratory interpretive reproducibilities for 24 control strains tested in three laboratories on three consecutive days were 97.0 and 95.7%, respectively. The equivalency of breakpoint results to category results obtained by the microdilution MIC procedure for 10,368 control organism-antimicrobial agent comparisons was 94.1%. The level of interpretive agreement between breakpoint and MIC category results using 101 fresh clinical isolates was 97.0% for 51 gram-negative and 50 gram-positive bacteria. Among the total 4,872 clinical organism-antimicrobial agent comparisons, major and very major discrepancies were seen in 0.2% of gram-negative bacteria and very major discrepancies were seen in 0.9% of gram-positive bacteria. All very major discrepancies with gram-positive organisms were associated with trailing endpoints using trimethoprim or sulfisoxazole and staphylococci. The breakpoint concept of testing selective antimicrobial agent concentrations was highly reproducible and accurate and allows for placement of more antimicrobial agents into a panel than is possible with full-dilution MIC testing.

UR - http://www.scopus.com/inward/record.url?scp=0023241901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023241901&partnerID=8YFLogxK

M3 - Article

C2 - 3693547

AN - SCOPUS:0023241901

VL - 25

SP - 2189

EP - 2192

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 11

ER -